Structural-functional relations of short analogs of enkephalin.
Rozental' G F; Chipens G I
BIOORGANICHESKAIA KHIMIIA (1986 Jul), 12(7), 869-97. (Russian)
The similarity of action of narcotic analgesics and opioid peptides is due to activation of a common opiate receptor as the primary step in initiating biochemical chains responsible for diverse morphine-like effects. The most widely used assays for opioid and analgesic activities are presented and evaluated.
Approximately 180 short enkephalin analogues (di-, tri- and tetrapeptides), described in the literature, are systematized and their opioid and systemic analgesic activities compared with methionine-enkephalin and morphine as the reference compounds, respectively.
The analysis of structure-opioid activity relationships among these enkephalin analogues substantiates the hypothesis that only a limited N-terminal region of the peptide molecule is essential for the binding of opioid peptides to the subclass of opiate receptors interacting with narcotic alkaloids (mu-receptors). An attempt has been made to identify minimal structural elements responsible for the mu-receptor activation. Shortening of the molecule and modification of its elements are examined with regard to the mu- and delta-receptor selectivity.
It is emphasized that the aromatic structure of the C-terminal region of the peptide is not obligatory for the mu-receptor binding. Modifications of short enkephalin analogues which might confer them antagonistic properties are reviewed. The correlation between the ability of short enkephalin analogues to interact with mu-receptors and their antinociceptive properties is discussed along with some structural features pertinent to the analgesic effect after systemic administration of peptides. On the basis of this analysis, peptides containing no more than four amino acids are considered as the most probable morphine-like analgesics.
Behavioral effects of d-opioid receptor agonists: potential antidepressants?
Broom, Daniel C.; Jutkiewicz, Emily M.; Rice, Kenner C.; Traynor, John R.; Woods, James H. Department of Pharmacology, University of Michigan Medical School, Ann Arbor, MI, USA.
Japanese Journal of Pharmacology (2002), 90(1), 1-6.
The development of selective d-opioid receptor agonists has revealed some very intriguing behavioral properties. d-Opioid agonists have antinociceptive, seizuregenic and convulsive properties. A no. of studies have identified a novel behavioral effect of d-opioid-receptor agonists, implicating a role for the d-opioid receptor in depression. Early clin. expts. demonstrated that exogenously administered opioid peptides had antidepressant activity in human patients.
Also, enkephalinase inhibitors, which prevent the degrdn. of endogenous enkephalins, produced antidepressant-like effects mediated through the d-opioid receptor in animal models of depression. More recently, the selective non-peptidic d-opioid agonists SNC80 and (+)BW373U86 demonstrated antidepressant-like activity in the forced swim assay in rats. These studies propose that the d-opioid receptor may provide a new therapeutic target for treating human depression.